The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Continuous blood glucose monitoring (CBGM) has emerged as a critical tool in managing diabetes, driving significant growth in the market. Let’s delve into the factors fueling this growth, technological advancements, and recent developments in the landscape.

Market Growth and Projections

• Current Market Size: $8.09 billion in 2023, projected to reach $9.68 billion in 2024, with a CAGR of 19.7%.
• Future Projections: Expected to expand to $20.44 billion by 2028, with a CAGR of 20.5%.

Role of Diabetes in Market Expansion

• Prevalence of Diabetes: Increasing global prevalence drives the demand for CBGM solutions.
• Enhanced Disease Management: CBGM devices aid in monitoring blood glucose levels, facilitating better disease management.
• Statistics: According to the International Diabetes Federation, approximately 537 million adults were affected by diabetes in 2021.

Technological Advancements Driving Growth

• Innovation in Sensor Technology: Companies focus on developing advanced sensors for more accurate monitoring.
• Integration with AI: Incorporation of artificial intelligence enhances data analysis and interpretation.
• Expansion of Wearable Technology: Wearable CBGM devices offer convenience and continuous monitoring capabilities.
• Remote Patient Monitoring: Increased focus on remote monitoring improves patient outcomes and engagement.

Read More On The Continuous Blood Glucose Monitoring Market Report 2024 – https://www.thebusinessresearchcompany.com/report/continuous-blood-glucose-monitoring-global-market-report

 Recent Developments in the Market

• Product Launch by DexCom Inc.: Dexcom One+ introduced as a customizable CGM system for real-time monitoring.
• Acquisition by Trinity Biotech: Acquisition of CGM assets from Waveform Technologies Inc. to enter the CGM market and strengthen product portfolio.

Market Segmentation

• Components: Insulin Pumps, Sensors, Transmitters, Receivers.
• Applications: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients.
• End Users: Hospitals, Homecare Diagnostics, and Others.

Leading Companies in the Market

• Key Players: Roche, LifeScan Inc., Medtronic, Abbott, and more.
• Focus Areas: Research and development of innovative CBGM solutions to meet evolving patient needs.

Regional Insights

• Dominance of North America: North America emerged as the largest region in the CBGM market in 2023.
• Global Expansion: Market growth expected across regions due to increasing diabetes prevalence and technological advancements.

Continuous blood glucose monitoring plays a vital role in diabetes management, offering patients real-time insights into their condition and empowering them to make informed decisions. With ongoing technological innovations and strategic acquisitions, the CBGM market is poised for remarkable growth, aiming to enhance patient outcomes and improve the quality of life for individuals living with diabetes.

Request for A Sample Of The Global Continuous Blood Glucose Monitoring Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13079&type=smp